What constitutes an "animal model of osteoarthritis" - the need for consensus?

Osteoarthritis and Cartilage

Volumn 20, Issue 4, 2012, Pages 261-267

  Little, C B ^a   Zaki, S ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Animal models; Osteoarthritis; Pain; Pathology

Indexed keywords

MICRORNA; OSTEOPROTEGERIN;

ALLODYNIA; ANTERIOR CRUCIATE LIGAMENT; ARTHRALGIA; CONSENSUS; DISABILITY; DISEASE MODEL; DISEASE SEVERITY; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; GENE MUTATION; HYPERALGESIA; MEDLINE; MOLECULAR DYNAMICS; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SPINAL GANGLION; STRUCTURE ANALYSIS; SYNOVITIS;

ANIMAL EXPERIMENTATION; ANIMALS; ARTHRITIS, EXPERIMENTAL; HUMANS; MICE; MICE, TRANSGENIC; OSTEOARTHRITIS; PAIN; PRACTICE GUIDELINES AS TOPIC; SPECIES SPECIFICITY;

EID: 84858624231     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.01.017     Document Type: Review

References (55)

1. Wehling M. Assessing the translatability of drug projects: what needs to be scored to predict success?. Nat Rev Drug Discov 2009, 8:541-546.
2. Wehling M. Drug development in the light of translational science: shine or shade?. Drug Discov Today 2011, 16:1076-1083.
3. Wendler A., Wehling M. The translatability of animal models for clinical development: biomarkers and disease models. Curr Opin Pharmacol 2010, 10:601-606.
4. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010, 8:e1000412.
5. Hooijmans C.R., de Vries R., Leenaars M., Curfs J., Ritskes-Hoitinga M. Improving planning, design, reporting and scientific quality of animal experiments by using the Gold Standard Publication Checklist, in addition to the ARRIVE guidelines. Br J Pharmacol 2011, 162:1259-1260.
6. Hooijmans C.R., Leenaars M., Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three Rs, and to make systematic reviews more feasible. Altern Lab Anim 2010, 38:167-182.
7. Little C., Smith M. Animal models of osteoarthritis. Curr Rheumatol Rev 2008, 4:175-182.
8. Smith M., Little C. Experimental models of osteoarthritis. Osteoarthitis: Diagnosis and Medical/Surgical Management 2007, 107-125. Lipincott Williams & Wilkins, Philadelphia. R. Moskowitz, R. Altman, M. Hochberg, J. Buckwalter, V. Goldberg (Eds.).
9. Little C. Experimental models of OA. OARSI Primer 2011, Y. Henrotin, D. Hunter, H. Kawaguchi (Eds.).
10. Driban J.B., Sitler M.R., Barbe M.F., Balasubramanian E. Is osteoarthritis a heterogeneous disease that can be stratified into subsets?. Clin Rheumatol 2010, 29:123-131.
11. Little C.B., Fosang A.J. Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis - insights from studies of aggrecan and collagen proteolysis?. Curr Drug Targets 2010, 11:561-575.
12. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006, 14:1033-1040.
13. Hunter D.J., March L., Sambrook P.N. The association of cartilage volume with knee pain. Osteoarthritis Cartilage 2003, 11:725-729.
14. Felson D.T. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009, 11:203.
15. Lo G.H., McAlindon T.E., Niu J., Zhang Y., Beals C., Dabrowski C., et al. Bone marrow lesions and joint effusion are strongly and independently associated with weight-bearing pain in knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthritis Cartilage 2009, 17:1562-1569.
16. Hill C.L., Hunter D.J., Niu J., Clancy M., Guermazi A., Genant H., et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599-1603.
17. Sengupta M., Zhang Y.Q., Niu J.B., Guermazi A., Grigorian M., Gale D., et al. High signal in knee osteophytes is not associated with knee pain. Osteoarthritis Cartilage 2006, 14:413-417.
18. Kornaat P.R., Bloem J.L., Ceulemans R.Y., Riyazi N., Rosendaal F.R., Nelissen R.G., et al. Osteoarthritis of the knee: association between clinical features and MR imaging findings. Radiology 2006, 239:811-817.
19. Amin S., Guermazi A., Lavalley M.P., Niu J., Clancy M., Hunter D.J., et al. Complete anterior cruciate ligament tear and the risk for cartilage loss and progression of symptoms in men and women with knee osteoarthritis. Osteoarthritis Cartilage 2008, 16:897-902.
20. Englund M., Niu J., Guermazi A., Roemer F.W., Hunter D.J., Lynch J.A., et al. Effect of meniscal damage on the development of frequent knee pain, aching, or stiffness. Arthritis Rheum 2007, 56:4048-4054.
21. Clements K.M., Ball A.D., Jones H.B., Brinckmann S., Read S.J., Murray F. Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis pain. Osteoarthritis Cartilage 2009, 17:805-812.
22. Guzman R.E., Evans M.G., Bove S., Morenko B., Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003, 31:619-624.
23. Barve R.A., Minnerly J.C., Weiss D.J., Meyer D.M., Aguiar D.J., Sullivan P.M., et al. Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease. Osteoarthritis Cartilage 2007, 15:1190-1198.
24. Baragi V.M., Becher G., Bendele A.M., Biesinger R., Bluhm H., Boer J., et al. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum 2009, 60:2008-2018.
25. Inglis J.J., McNamee K.E., Chia S.L., Essex D., Feldmann M., Williams R.O., et al. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum 2008, 58:3110-3119.
26. McNamee K.E., Burleigh A., Gompels L.L., Feldmann M., Allen S.J., Williams R.O., et al. Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain 2010, 149:386-392.
27. Knights C.B., Gentry C., Bevan S. Partial medial meniscectomy produces osteoarthritis pain-related behaviour in female C57BL/6 mice. Pain 2012, 153:281-292.
28. Ferland C.E., Laverty S., Beaudry F., Vachon P. Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav 2011, 97:603-610.
29. Im H.J., Kim J.S., Li X., Kotwal N., Sumner D.R., van Wijnen A.J., et al. Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 2010, 62:2995-3005.
30. McGaraughty S., Chu K.L., Perner R.J., Didomenico S., Kort M.E., Kym P.R. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain 2010, 6:14.
31. Yoshimi E., Kumakura F., Hatori C., Hamachi E., Iwashita A., Ishii N., et al. Antinociceptive effects of AS1892802, a novel Rho kinase inhibitor, in rat models of inflammatory and noninflammatory arthritis. J Pharmacol Exp Ther 2010, 334:955-963.
32. Aigner T., Cook J.L., Gerwin N., Glasson S.S., Laverty S., Little C.B., et al. Histopathology atlas of animal model systems - overview of guiding principles. Osteoarthritis Cartilage 2010, 18(Suppl 3):S2-S6.
33. Poole R., Blake S., Buschmann M., Goldring S., Laverty S., Lockwood S., et al. Recommendations for the use of preclinical models in the study and treatment of osteoarthritis. Osteoarthritis Cartilage 2010, 18(Suppl 3):S10-S16.
34. Okamura N., Hasegawa M., Nakoshi Y., Iino T., Sudo A., Imanaka-Yoshida K., et al. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage 2010, 18:839-848.
35. Glasson S., Blanchet T., Ma H., Hopkins B., Diane P., Carito B., et al. Evaluation of twelve knock-out mice following surgical induction of osteoarthritis. Trans Orth Res Soc 2006, 31:216.
36. Glasson S., Hopkins B., Attipoe S., Schelling S., Morris E. ADAMTS-5 KO mice are protected in a long-term instability model of osteoarthritis. Trans Orth Res Soc 2007, 57:83.
37. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
38. Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., Ma H.L., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004, 50:2547-2558.
39. Majumdar M.K., Askew R., Schelling S., Stedman N., Blanchet T., Hopkins B., et al. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 2007, 56:3670-3674.
40. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005, 434:648-652.
41. Little C.B., Meeker C.T., Golub S.B., Lawlor K.E., Farmer P.J., Smith S.M., et al. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest 2007, 117:1627-1636.
42. Otsuki S., Hanson S.R., Miyaki S., Grogan S.P., Kinoshita M., Asahara H., et al. Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci U S A 2010, 107:10202-10207.
43. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
44. Chia S.L., Sawaji Y., Burleigh A., McLean C., Inglis J., Saklatvala J., et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009, 60:2019-2027.
45. Shimizu S., Asou Y., Itoh S., Chung U.I., Kawaguchi H., Shinomiya K., et al. Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. Arthritis Rheum 2007, 56:3358-3365.
46. Yang S., Kim J., Ryu J.H., Oh H., Chun C.H., Kim B.J., et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010, 16:687-693.
47. Miyaki S., Sato T., Inoue A., Otsuki S., Ito Y., Yokoyama S., et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010, 24:1173-1185.
48. Matsui Y., Iwasaki N., Kon S., Takahashi D., Morimoto J., Matsui Y., et al. Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 2009, 60:2362-2371.
49. Blom A.B., van Lent P.L., Libregts S., Holthuysen A.E., van der Kraan P.M., van Rooijen N., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56:147-157.
50. Glasson S.S. In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr Drug Targets 2007, 8:367-376.
51. Lories R.J., Peeters J., Bakker A., Tylzanowski P., Derese I., Schrooten J., et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum 2007, 56:4095-4103.
52. de Hooge A.S., van de Loo F.A., Bennink M.B., Arntz O.J., de Hooge P., van den Berg W.B. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthritis Cartilage 2005, 13:66-73.
53. Ryu J.H., Yang S., Shin Y., Rhee J., Chun C.H., Chun J.S. Interleukin 6 plays an essential role in hypoxia-inducible factor-2alpha-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum 2011, 63:2732-2743.
54. van Lent P., Blom A., Schelbergen R., Sloetjes A., Nacken W., Vogl T., et al. Active involvement of alarmins S100A8 and S100A9 in regulation of synovial activation and joint destruction during osteoarthritis. Trans Orth Res Soc 2010, 56:347.
55. van Lent P.L., Grevers L., Blom A.B., Sloetjes A., Mort J.S., Vogl T., et al. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008, 67:1750-1758.